true

Anticoagulants

Partner with BD to bring your anticoagulant to market

Woman comforting patient in hospital bed

Anticoagulants

Anticoagulant Medications

Strokes, heart attacks and deep vein thrombosis caused by blood clots are a significant cause of morbidity and mortality across the globe.

Typically, treatments for blood clots such as heparin are administered parenterally.

Low molecular weight heparins (LMWH) are also used prophylactically for people going for surgery, to prevent clot formation in the post-surgical period.

In all these cases, anticoagulant prefilled glass syringes can play an important role. It has been shown that prefillable syringes provide:

  • ps_anticoagulant_reduction_icon

    Reduced administration error1

  • ps_anticoagulant_safety_icon

    Patient safety1

  • ps_anticoagulant_ready-to-admin_icon

    "Ready-to-administer" solutions1

  • ps_anticoagulant_waste_icon

    Reduced waste1

Addressing Your Needs

Bringing years of experience to your injectable anticoagulant

With over 40 years of experience in the anticoagulant area, BD has established a reputation of reliability, reinforcing our commitment to enable pharmaceutical customer success and improve patient well-being.

  • ps_anticoagulant_quality_icon

    With 70% of leaders in the pharmaceutical industry choosing to work with us, we stand for supply assurance and quality.2

  • ps_anticoagulant_ww_icon

    BD glass prefillable syringes are one of the most used prefillable syringes in the world and BD is accountable for the first prefillable syringes for LMWH.3-5

  • ps_anticoagulant_pfs_icon

    BD remains a key partner for pharmaceutical companies focusing on anticoagulants delivered in prefilled glass syringes.

  • ps_anticoagulant_customer-centric_icon

    You can also partner with us to benefit from our customer-centric approach, which is based on our experience and expertise, while taking into account your specific requirements. 

  • ps_anticoagulant_experts_icon

    Our teams of experts will support the  development of your combination product, from meeting regulatory body requirements right through to market launch. 

  • ps_anticoagulant_process_icon

    Your product will benefit from our standardized quality processes and products, which are continually supported by improvement programs. 

  • ps_anticoagulant_network_icon

    Finally, our multi-sourcing network supports business continuity, meaning you can enjoy peace of mind due to our high-volume production capacity.

Anticoagulant_bd hypak glass pfs large

BD Hypak™ Glass Prefillable Syringe for Anticoagulants

One of the most commonly used prefillable syringes in the world3

  • BD Hypak™ Glass Prefillable Syringe is a standard prefillable drug delivery systems that is designed to administer subcutaneous anticoagulants
  • BD Hypak™  Glass Prefillable Syringe is compatible with the BD Preventis™ Needle Shielding System
  • BD Hypak™  Glass Prefillable Syringe features a staked needle that is ready to use, and no needle connection is required


Choose BD to bring your drug to market

Backed by more than 60 years of experience, BD prefillable syringes
and services support medication delivery to benefit you, patients and clinicians

 

Explore our products

 

Partner with BD

At BD, we're committed to partnering with you to help solve your drug delivery challenges. Are you ready to connect?

Contact us
For sales inquiries, technical support and customer support complete the following form:
Notes
  1. Dan Benhamou, et. al. "Assessing the Clinical, Economic, and Health Resource Utilization Impacts of Prefilled Syringes Versus Conventional Medication Administration Methods: Results From a Systematic Literature Review" - Annals of Pharmacotherapy, 1-14, 2023
  2. Internal Top 100 Pharma analysis: triangulation of IQVIA data with internal performance (2021 annual sales)
  3. BD analysis, based on TMC study, IQVIA data [internal analysis]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2022
  4. Lovenox, USPI, Apr 2022
  5. Aspen, General presentation, Accessed 19 /05 /2022; 2021

 

true